McCourt Marion sold REGN
February 1, 2024 · Form 4 insider transaction
McCourt Marion sold 273 shares of Regeneron Pharmaceuticals, Inc. at $945.61 per share, a transaction worth $258.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
273
Price
$945.61
Total value
$258.2K
InsiderMcCourt Marion
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 1, 2024
Filing dateFebruary 2, 2024
Shares owned after14,789
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023.